They demonstrated that the activation of TRPV3 can induce the production of IL-33, which plays an important role in the pathogenesis of the pruritus in AD, suggesting the use of the TRPV3 channel as a possible target therapy [31]. The gene discussed is IL33; the disease is Alzheimer disease.